JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB41651

Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6]

Be the first to review this product! Submit a review

|

(9 Publications)

Mouse Monoclonal POLG antibody. Suitable for Flow Cyt, ELISA, WB, IHC-FoFr, ICC/IF and reacts with Japanese encephalitis virus samples. Cited in 9 publications.

View Alternative Names

Genome polyprotein

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6] (AB41651)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6] (AB41651)

Japanese encephalitis virus (Nakayama) infected PS clone D cells stained with ab41651 (green).

Western blot - Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6] (AB41651)
  • WB

Unknown

Western blot - Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6] (AB41651)

This antibody recognsies 2 forms of NS1 - NS1 and NS1' (46 and 53 kDa respectively). NS1' is thought to be formed when NS1 is cleaved from NS2A at an alternative site. Both NS1 and NS1' exist as dimers in untreated samples but are dissociated into monomers when samples are boiled.

All lanes:

Western blot - Anti-Japanese encephalitis virus NS1 glycoprotein antibody [MV12/2/A5-1/6] (ab41651)

Lane 1:

Japanese encephalitis virus infected C6/36 cell lysate (unheated)

Lane 2:

Japanese encephalitis virus infected C6/36 cell lysate (boiled)

Predicted band size: 46 kDa

Observed band size: 100 kDa,46 kDa,50 kDa,92 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

MV12/2/A5-1/6

Isotype

IgG3

Light chain type

kappa

Carrier free

No

Reacts with

Japanese encephalitis virus

Applications

Flow Cyt, WB, ELISA, IHC-FoFr, ICC/IF

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCFoFr" : {"fullname" : "Immunohistochemistry (PFA perfusion fixed frozen sections)", "shortname":"IHC-FoFr"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Japanese encephalitis virus": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/unavailable/mouse-igg3-kappa-monoclonal-mg3-35-isotype-control-low-endotoxin-azide-free-ab18392'>ab18392</a> - Mouse monoclonal IgG3, is suitable for use as an isotype control with this antibody.</p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/50 - 1/100", "WB-species-notes": "<p></p>", "IHCFoFr-species-checked": "guaranteed", "IHCFoFr-species-dilution-info": "", "IHCFoFr-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/5 - 1/20", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
Preservative: 0.1% Proclin 150 Constituents: 89.9% RPMI 1640, 10% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Japanese encephalitis virus NS1 glycoprotein also known as NS1 is an important non-structural protein in the lifecycle of the Japanese encephalitis virus. It has a molecular mass of approximately 46 kDa and is expressed in both the infected host cells and the virus itself. NS1 plays an important role in viral replication and immune evasion making it a significant focus of research. It is expressed on the surface of infected cells as a dimer or can be secreted as a hexamer providing multiple functional roles and making it a target for antibody development.
Biological function summary

The NS1 glycoprotein participates in the virus's evasion of the host's immune system. It doesn't operate as part of a complex but serves several independent functions. NS1 helps inhibit the host's complement system reducing the immune-mediated damage to the virus-infected cells. Additionally it assists in viral RNA synthesis by enhancing the efficiency of the viral replication complex supporting the production of new viral particles within the infected cell environment.

Pathways

The NS1 glycoprotein interacts with several host cell mechanisms to modulate the immune response. Specifically it is involved in the complement inhibition and RNA synthesis pathways. In the complement inhibition pathway NS1 plays a part by binding to host complement proteins impeding their function and providing an advantage to the virus against the host immune defense. Its association with the viral RNA synthesis pathway is essential for the replication of the Japanese encephalitis virus coordinating with other non-structural proteins like NS3 to ensure effective viral proliferation.

NS1 is closely linked to the pathogenesis of Japanese encephalitis and other flavivirus-related conditions. The protein's interaction with host immune responses directly correlates with the severity of these diseases by contributing to immune evasion and facilitating virus spread within the host. Additionally NS1 has been observed to share functional similarities with proteins of other viruses including dengue virus NS1 which plays a similar role in disrupting immune pathways and aiding in viral replication. Understanding these connections helps in developing effective strategies for therapeutic interventions against flaviviruses.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Capsid protein C. Plays a role in virus budding by binding to the cell membrane and gathering the viral RNA into a nucleocapsid that forms the core of a mature virus particle. During virus entry, may induce genome penetration into the host cytoplasm after hemifusion induced by the surface proteins. Can migrate to the cell nucleus where it modulates host functions. Overcomes the anti-viral effects of host EXOC1 by sequestering and degrading the latter through the proteasome degradation pathway.. Capsid protein C. Inhibits RNA silencing by interfering with host Dicer.. Peptide pr. Prevents premature fusion activity of envelope proteins in trans-Golgi by binding to envelope protein E at pH 6.0. After virion release in extracellular space, gets dissociated from E dimers.. Protein prM. Acts as a chaperone for envelope protein E during intracellular virion assembly by masking and inactivating envelope protein E fusion peptide. prM is the only viral peptide matured by host furin in the trans-Golgi network probably to avoid catastrophic activation of the viral fusion activity in acidic Golgi compartment prior to virion release. prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion.. Small envelope protein M. May play a role in virus budding. Exerts cytotoxic effects by activating a mitochondrial apoptotic pathway through M ectodomain. May display a viroporin activity.. Envelope protein E. Binds to host cell surface receptor and mediates fusion between viral and cellular membranes. Efficient virus attachment to cell is, at least in part, mediated by host HSPA5 (PubMed : 28053106). Envelope protein is synthesized in the endoplasmic reticulum in the form of heterodimer with protein prM. They play a role in virion budding in the ER, and the newly formed immature particle is covered with 60 spikes composed of heterodimer between precursor prM and envelope protein E. The virion is transported to the Golgi apparatus where the low pH causes dissociation of PrM-E heterodimers and formation of E homodimers. prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion.. Non-structural protein 1. Involved in immune evasion, pathogenesis and viral replication. Once cleaved off the polyprotein, is targeted to three destinations : the viral replication cycle, the plasma membrane and the extracellular compartment. Essential for viral replication. Required for formation of the replication complex and recruitment of other non-structural proteins to the ER-derived membrane structures. Excreted as a hexameric lipoparticle that plays a role against host immune response. Antagonizing the complement function. Binds to the host macrophages and dendritic cells. Inhibits signal transduction originating from Toll-like receptor 3 (TLR3).. Non-structural protein 2A. Component of the viral RNA replication complex that functions in virion assembly and antagonizes the host alpha/beta interferon antiviral response.. Serine protease subunit NS2B. Required cofactor for the serine protease function of NS3 (PubMed : 7897348). May have membrane-destabilizing activity and form viroporins (By similarity).. Serine protease NS3. Displays three enzymatic activities : serine protease, NTPase and RNA helicase (PubMed : 18201743, PubMed : 7897348). NS3 serine protease, in association with NS2B, performs its autocleavage and cleaves the polyprotein at dibasic sites in the cytoplasm : C-prM, NS2A-NS2B, NS2B-NS3, NS3-NS4A, NS4A-2K and NS4B-NS5 (Probable). NS3 RNA helicase binds RNA and unwinds dsRNA in the 3' to 5' direction (By similarity).. Non-structural protein 4A. Regulates the ATPase activity of the NS3 helicase activity (By similarity). NS4A allows NS3 helicase to conserve energy during unwinding (By similarity).. Peptide 2k. Functions as a signal peptide for NS4B and is required for the interferon antagonism activity of the latter.. Non-structural protein 4B. Induces the formation of ER-derived membrane vesicles where the viral replication takes place (By similarity). Inhibits interferon (IFN)-induced host STAT1 phosphorylation and nuclear translocation, thereby preventing the establishment of cellular antiviral state by blocking the IFN-alpha/beta pathway (By similarity). Inhibits STAT2 translocation in the nucleus after IFN-alpha treatment (By similarity).. RNA-directed RNA polymerase NS5. Replicates the viral (+) and (-) RNA genome (PubMed : 24293643). Performs the capping of genomes in the cytoplasm. NS5 methylates viral RNA cap at guanine N-7 and ribose 2'-O positions (By similarity). Besides its role in RNA genome replication, also prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) signaling pathway (PubMed : 16731929). Inhibits host TYK2 and STAT2 phosphorylation, thereby preventing activation of JAK-STAT signaling pathway (PubMed : 16731929).
See full target information Genome polyprotein

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

The Journal of general virology 102: PubMed33095129

2020

Japanese encephalitis virus capsid protein interacts with non-lipidated MAP1LC3 on replication membranes and lipid droplets.

Applications

Unspecified application

Species

Unspecified reactive species

Riya Sarkar,Kiran Bala Sharma,Anita Kumari,Shailendra Asthana,Manjula Kalia

Nature communications 9:673 PubMed29445153

2018

Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Feng Li,Hao-Long Dong,Hong-Jiang Wang,Xing-Yao Huang,Ye-Feng Qiu,Xue Ji,Qing Ye,Chunfeng Li,Yang Liu,Yong-Qiang Deng,Tao Jiang,Gong Cheng,Fu-Chun Zhang,Andrew D Davidson,Ya-Jun Song,Pei-Yong Shi,Cheng-Feng Qin

Scientific reports 6:27685 PubMed27282499

2016

Japanese Encephalitis Virus exploits the microRNA-432 to regulate the expression of Suppressor of Cytokine Signaling (SOCS) 5.

Applications

WB

Species

Japanese encephalitis virus

Nikhil Sharma,Kanhaiya L Kumawat,Meghana Rastogi,Anirban Basu,Sunit K Singh

Journal of neuroinflammation 12:30 PubMed25889446

2015

miR-146a suppresses cellular immune response during Japanese encephalitis virus JaOArS982 strain infection in human microglial cells.

Applications

WB

Species

Japanese encephalitis virus

Nikhil Sharma,Ruhi Verma,Kanhaiya Lal Kumawat,Anirban Basu,Sunit K Singh

Autophagy 10:1637-51 PubMed25046112

2014

Japanese encephalitis virus replication is negatively regulated by autophagy and occurs on LC3-I- and EDEM1-containing membranes.

Applications

Unspecified application

Species

Unspecified reactive species

Manish Sharma,Sankar Bhattacharyya,Minu Nain,Manpreet Kaur,Vikas Sood,Vishal Gupta,Renu Khasa,Malik Z Abdin,Sudhanshu Vrati,Manjula Kalia

Journal of virology 87:13694-705 PubMed24109223

2013

A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Feng Li,Yong-Qiang Deng,Hui-Qiang Yang,Hui Zhao,Tao Jiang,Xue-Dong Yu,Shi-Hua Li,Qing Ye,Shun-Ya Zhu,Hong-Jiang Wang,Yu Zhang,Jie Ma,Yong-Xin Yu,Zhong-Yu Liu,Yu-Hua Li,E-De Qin,Pei-Yong Shi,Cheng-Feng Qin

PloS one 7:e30259 PubMed22276167

2012

Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics.

Applications

WB

Species

Japanese encephalitis virus

Ting Zhang,Zhiqiang Wu,Jiang Du,Yongfeng Hu,Liguo Liu,Fan Yang,Qi Jin

Journal of immunology (Baltimore, Md. : 1950) 185:1429-41 PubMed20581148

2010

Multifront assault on antigen presentation by Japanese encephalitis virus subverts CD8+ T cell responses.

Applications

Flow Cyt

Species

Unspecified reactive species

Abi G Aleyas,Young Woo Han,Junu A George,Bumseok Kim,Koanhoi Kim,Chong-Kil Lee,Seong Kug Eo

Journal of immunology (Baltimore, Md. : 1950) 183:2462-74 PubMed19635909

2009

Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways.

Applications

IHC-FoFr

Species

Unspecified reactive species

Abi G Aleyas,Junu A George,Young Woo Han,M M Rahman,Seon Ju Kim,Sang Bae Han,Byung Sam Kim,Koanhoi Kim,Seong Kug Eo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com